These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 978671

  • 21. Design of exo affinity labeling reagents.
    Cory M, Andrews JM, Bing DH.
    Methods Enzymol; 1977; 46():115-30. PubMed ID: 909401
    [No Abstract] [Full Text] [Related]

  • 22. Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives.
    Nadri H, Pirali-Hamedani M, Shekarchi M, Abdollahi M, Sheibani V, Amanlou M, Shafiee A, Foroumadi A.
    Bioorg Med Chem; 2010 Sep 01; 18(17):6360-6. PubMed ID: 20673725
    [Abstract] [Full Text] [Related]

  • 23. [C1-inactivator from guinea pig-serum mechanism of action. II. Effect of the inactivator on C1 in its bound form: EAC1, EAC14b and EAC14b2a].
    Loos M.
    Z Med Mikrobiol Immunol; 1971 Sep 01; 156(2):221-32. PubMed ID: 5554814
    [No Abstract] [Full Text] [Related]

  • 24. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
    Wang C, Wu Z, Cai H, Xu S, Liu J, Jiang J, Yao H, Wu X, Xu J.
    Bioorg Med Chem Lett; 2015 Nov 15; 25(22):5212-6. PubMed ID: 26454504
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A, Boumsell L, Borsos.
    J Immunol; 1975 Oct 15; 115(4):1091-4. PubMed ID: 1176767
    [Abstract] [Full Text] [Related]

  • 29. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor.
    Grue-Sørensen G, Nielsen IM, Nielsen CK.
    J Med Chem; 1988 Jun 15; 31(6):1174-8. PubMed ID: 3373485
    [Abstract] [Full Text] [Related]

  • 30. Nucleophilic addition to 3-substituted pyridinium salts: expedient syntheses of (-)-L-733,061 and (-)-CP-99,994.
    Lemire A, Grenon M, Pourashraf M, Charette AB.
    Org Lett; 2004 Sep 30; 6(20):3517-20. PubMed ID: 15387537
    [Abstract] [Full Text] [Related]

  • 31. Synthesis of pyridinium analogues of acetylcholine and their interactions with intestinal muscarinic receptors.
    Kuhnen-Clausen D, Hagedorn I, Bill R.
    J Med Chem; 1979 Feb 30; 22(2):177-80. PubMed ID: 423196
    [Abstract] [Full Text] [Related]

  • 32. Inhibitory effects of newly synthesized active center-directed trypsin-like serine protease inhibitors on the complement system.
    Ueda N, Midorikawa A, Ino Y, Oda M, Nakamura K, Suzuki S, Kurumi M.
    Inflamm Res; 2000 Jan 30; 49(1):42-6. PubMed ID: 10778920
    [Abstract] [Full Text] [Related]

  • 33. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.
    Alipour M, Khoobi M, Foroumadi A, Nadri H, Moradi A, Sakhteman A, Ghandi M, Shafiee A.
    Bioorg Med Chem; 2012 Dec 15; 20(24):7214-22. PubMed ID: 23140986
    [Abstract] [Full Text] [Related]

  • 34. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W, Loos M, Ringelmann R.
    Z Med Mikrobiol Immunol; 1971 Dec 15; 156(2):194-207. PubMed ID: 4995249
    [No Abstract] [Full Text] [Related]

  • 35. Antidotal efficacy of pyridinium oximes and cholineacetyltransferase inhibitors against organophosphorus intoxication in rodents.
    Dube SN, Kumar D, Acharya J, Dubey DK, Purnanand, Sikder AK.
    Indian J Physiol Pharmacol; 2000 Jan 15; 44(1):50-6. PubMed ID: 10919095
    [Abstract] [Full Text] [Related]

  • 36. Synthesis, antibacterial and antioxidant activities of new 1-alkyl-4-(1-alkyl-4-oxo-1,4-dihydroquinolin-2-yl)pyridinium bromides.
    Kahriman N, Yaylı B, Aktaş A, Iskefiyeli Z, Beriş FŞ, Yaylı N.
    Eur J Med Chem; 2013 Nov 15; 69():348-55. PubMed ID: 24077525
    [Abstract] [Full Text] [Related]

  • 37. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity.
    Chennamaneni SR, Vobalaboina V, Garlapati A.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3076-80. PubMed ID: 15908205
    [Abstract] [Full Text] [Related]

  • 38. LUMO energy of model compounds of bispyridinium compounds as an index for the inhibition of choline kinase.
    Campos J, del Carmen Núñez M, Rodríguez V, Entrena A, Hernández-Alcoceba R, Fernández F, Lacal JC, Gallo MA, Espinosa A.
    Eur J Med Chem; 2001 Mar 15; 36(3):215-25. PubMed ID: 11337100
    [Abstract] [Full Text] [Related]

  • 39. The catabolism of intact, reactive centre-cleaved and proteinase-complexed C1 inhibitor in the guinea pig.
    Malek R, Aulak KS, Davis AE.
    Clin Exp Immunol; 1996 Jul 15; 105(1):191-7. PubMed ID: 8697630
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and hypoglycemic activity of some substituted 2-arylthiazolo[3,2-a]pyridinium salts.
    Blank B, DiTullio NW, Krog AJ, Saunders HL.
    J Med Chem; 1978 May 15; 21(5):489-92. PubMed ID: 660598
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.